1887

Abstract

The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs) are increasingly being reported. Here, we used the SpeeDx ResistancePlus MG kit, which provides simultaneous detection of M. genitalium and MRMMs, to assess MRMM carriage among M. genitalium infections in Queensland, Australia. Performance characteristics of the ResistancePlus MG kit for M. genitalium detection were compared to in-house PCR. Available M. genitalium PCR-positive (n=67) and negative (n=281) samples from the years 2011 to 2017 were tested using the SpeeDx ResistancePlus MG kit. In total, 63.6 % M. genitalium-positive samples were indicated to harbour MRMMs. The ResistancePlus MG method provided sensitivity and specificity of 97 and 99.6 % respectively compared to in-house PCR for M. genitalium detection. Such high levels of macrolide-resistant M. genitalium raise further concerns over future use of azithromycin for treatment of M. genitalium infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000584
2017-09-12
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/10/1451.html?itemId=/content/journal/jmm/10.1099/jmm.0.000584&mimeType=html&fmt=ahah

References

  1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24: 498– 514 [CrossRef] [PubMed]
    [Google Scholar]
  2. Shahmanesh M, Moi H, Lassau F, Janier M. IUSTI/WHO 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS 2009; 20: 458– 464 [CrossRef] [PubMed]
    [Google Scholar]
  3. Workowski KA, Bolan GA. Centers for disease c, prevention. sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 1– 137 [Crossref]
    [Google Scholar]
  4. Björnelius E, Magnusson C, Jensen JS. Mycoplasma genitalium macrolide resistance in Stockholm, Sweden. Sex Transm Infect 2017; 93: 167– 168 [CrossRef] [PubMed]
    [Google Scholar]
  5. Chernesky MA, Jang D, Martin I, Hoang LMN, Naidu P et al. Mycoplasma genitalium antibiotic resistance-mediating mutations in Canadian women with or without chlamydia trachomatis infection. Sex Transm Dis 2017; 44: 433– 435 [CrossRef] [PubMed]
    [Google Scholar]
  6. Basu I, Roberts SA, Bower JE, Henderson G, Reid M. High macrolide resistance in Mycoplasma genitalium strains causing infection in Auckland, New Zealand. J Clin Microbiol 2017; 55: 2280– 2282 [CrossRef] [PubMed]
    [Google Scholar]
  7. Read TR, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L et al. Azithromycin 1.5g over 5 days compared to 1g single dose in urethral Mycoplasma genitalium: impact on treatment outcome and resistance. Clin Infect Dis 2017; 64: 250– 256 [CrossRef] [PubMed]
    [Google Scholar]
  8. Tabrizi SN, Su J, Bradshaw CS, Fairley CK, Walker S et al. Prospective evaluation of resistanceplus MG, a new multiplex quantitative PCR assay for detection of Mycoplasma genitalium and macrolide resistance. J Clin Microbiol 2017; 55: 1915– 1919 [CrossRef] [PubMed]
    [Google Scholar]
  9. Jensen JS, Björnelius E, Dohn B, Lidbrink P. Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 2004; 42: 683– 692 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000584
Loading
/content/journal/jmm/10.1099/jmm.0.000584
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error